Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
10th Floor, Menara Hap Seng,No. 1 & 3, Jalan P. Ramlee, City
Kuala Lumpur; Federal Territories; Map
Postal Code: 50250
Tel: +60-3-2382-
Fax: +60-3-2382-
Email: @sunzenbio.com
Website: http://www.sunzen.com.my

Full name: Sunzen Biotech Berhad

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 2412931
ISIN: MYQ0148OO005
Incorporation Date: 2005

Main Activities

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences

Company Description

Sunzen Biotech Berhad engages in the biotechnology research and production of animal health products (feed supplement). The principal activities of the subsidiaries are R&D and commercialisation of in-feed anti bacterial products and supplements for animal health products, the distribution and marketing of animal health products. The group consists of Sunzen Biotech and wholly owned subsidiaries namely Sunzen Corporation, Sunzen LifeSciences and Sunzen Feedtech. The Company was incorporated in 2005 and is…

More

Basic Information

Outstanding Shares:
: ()
Financial Auditors:
()

EMIS Benchmark Score

View all parameters in Benchmark Score

Quote Chart

Quote Summary

Last Price 0.3450
Volume 4,619,800
Turnover 1,559,183
Index
Market Bursa Malaysia
Ticker 148
Market Cap Market Cap 158,113
52 Week High 0.3450
52 Week Low 0.2000
Price to Earnings (P/E) -2635.22
Earnings per Share (EPS)
Dividend Yield 0.01 (December 31, 2014)
Bookvalue 102,467
Enterprise Value 112,238
Quote updated on April 28, 2017
Note: data in MYR Thousands.

Key Executives

Chairman
More

Ownership Details

Choon Hau Hong
27.44%
Other

Key Stats

Select Items to chart them. 2016 Y
Net sales revenue
Total operating revenue
Operating profit (EBIT)
EBITDA
Net Profit (Loss) for the Period
Total assets 106,585
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.

Financials

Competitors - Malaysia

MYR | USD | EUR

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full PDF report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest